Taiwan
June 23, 2026
5A
Type: Global Innovation Hub Session
Taiwan has targeted precision health, advanced manufacture, and digital health as its key elements for biomedical industry development. Besides a well-established infrastructure and various unique biomedical clusters, the government has launched regulations to promote new sectors of biomedical industry, such as cell therapies, digital health, and CDMO. This presentation will update the progress for the biomedical ecosystem in Taiwan, including incentives for advancing together with Taiwanese partners.
Company HQ City:
Taipei
Company HQ Country:
Taiwan
Primary Speaker
)
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}